A
Anhui Anke Biotechnology
Anhui Anke Biotechnology is a biopharmaceutical high-tech enterprise based in China
At a glance
- Founded
- 1994
- Headquarters
- Hefei, China
- Listing
- IPO 2009
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tierThoroughbred$100M+ revenue
Latest news
Press, funding announcements and product moves mentioning Anhui Anke Biotechnology.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
- GGGood Capital Group
Series B and later1 investor entered at this stage
- ABAnhui Institute of Biology
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
234 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where Anhui Anke Biotechnology was the backer or acquirer, 2017–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
3 deals across Anhui Anke Biotechnology's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Anhui Anke Biotechnology's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Anhui Anke Biotechnology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Anhui Anke Biotechnology on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.